CN110272731B - Fluorescent probe DCCO and preparation method and application thereof - Google Patents
Fluorescent probe DCCO and preparation method and application thereof Download PDFInfo
- Publication number
- CN110272731B CN110272731B CN201910634808.8A CN201910634808A CN110272731B CN 110272731 B CN110272731 B CN 110272731B CN 201910634808 A CN201910634808 A CN 201910634808A CN 110272731 B CN110272731 B CN 110272731B
- Authority
- CN
- China
- Prior art keywords
- fluorescent probe
- dcco
- clo
- fluorescence
- dissolving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000012043 crude product Substances 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims abstract description 5
- QGJXVBICNCIWEL-UHFFFAOYSA-N 9-ethylcarbazole-3-carbaldehyde Chemical compound O=CC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 QGJXVBICNCIWEL-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000004440 column chromatography Methods 0.000 claims abstract description 4
- 238000010828 elution Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims abstract description 4
- 238000010992 reflux Methods 0.000 claims abstract description 4
- 238000000926 separation method Methods 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 3
- 238000001914 filtration Methods 0.000 claims abstract description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 230000004044 response Effects 0.000 claims description 9
- 238000002474 experimental method Methods 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 6
- 238000004448 titration Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 4
- 238000003556 assay Methods 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 239000003480 eluent Substances 0.000 claims 1
- 238000001917 fluorescence detection Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 13
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 239000012472 biological sample Substances 0.000 abstract description 4
- QXAMGWKESXGGNV-UHFFFAOYSA-N 7-(diethylamino)-1-benzopyran-2-one Chemical group C1=CC(=O)OC2=CC(N(CC)CC)=CC=C21 QXAMGWKESXGGNV-UHFFFAOYSA-N 0.000 abstract description 2
- 238000003384 imaging method Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 241000252212 Danio rerio Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 150000001450 anions Chemical class 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 241000219194 Arabidopsis Species 0.000 description 3
- 241000219195 Arabidopsis thaliana Species 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
Abstract
The invention provides a fluorescent probe DCCO and a preparation method and application thereof. The fluorescent probe is 7- (diethylamino) -3- (E) -3- (9-ethyl-9H-carbazole-3-yl) acryloyl) -2H-pyran-2-one. The preparation method comprises the following steps: dissolving 3-acetyl-7- (diethylamino) -2H-pyran-2-one and 9-ethyl-9H-carbazole-3-formaldehyde in an ethanol/acetonitrile (1/1, V/V) mixed solution according to an equal molar ratio, dripping piperidine, heating and refluxing, and changing the solution from orange to red; removing the solvent under reduced pressure, and performing column chromatography separation by a gradient elution method to obtain a crude product of the fluorescent probe; dissolving with diethyl ether, filtering, and drying to obtain pure product. The fluorescent probe pair ClO‑The detection is ratio-type, shows high sensitivity and good selectivity and stability, and has the advantages of simple and rapid detection process, accurate detection result and the like. The fluorescent probe DCCO can be used for biological sample ClO‑The method is applied to detection.
Description
Technical Field
The invention relates to an organic small molecule fluorescent probe, in particular to a fluorescent probe DCCO and a preparation method thereof, and application of the fluorescent probe to ClO in a biological sample-Detection of (3).
Background
For over 100 years, ClO-Is used as a clinical general disinfectant as an effective drug against various microorganisms. In animals and humans, ClO-Is also considered to be a key bactericide during the immune response, corresponding to the digestion process of neutrophils phagocytizing bacteria. However, in inflammatory states, excessive production of HClO may trigger or exacerbate a variety of diseases, including Alzheimer's disease, cardiovascular disease, atherosclerosis, inflammatory bowel disease, myocardial infarction, organ transplant rejection, and even cancer. Therefore, there is an urgent need to develop a method for detecting ClO in an organism-A fast and efficient tool.
Methods for detecting hypochlorous acid or hypochlorite exist at present, such as chromatography, chemiluminescence, electroanalysis and the like. However, these methods have low sensitivity and complicated operation, and more importantly, cannot be applied to HClO/ClO in vivo-Detection of (3). And the fluorescent probe is used as the most powerful tool for detecting the analyteOne of them, because they have high sensitivity, simple operation, do not need to help the complicated instrument to realize the analyte detection, and also have easy visualization intracellular dynamics and high resolution to locate the interested biological molecules, ratio type fluorescent probe has two independent fluorescent signals, can avoid the background interference better. Fluorescence imaging is carried out by a laser confocal microscope, so that the hypochlorite in the organism can be detected. Therefore, there is an urgent need for the synthesis of ClO probes for detecting biological samples, which have the advantages of simplicity, high sensitivity, good selectivity, low detection limit and good photostability-。
Disclosure of Invention
One of the purposes of the invention is to provide a fluorescent probe DCCO. The other purpose is to provide a preparation method of the probe DCCO, which has simple preparation process and low cost. The third purpose is to provide the application of the probe, namely the application of the probe in ClO in biological samples-Detection of (3). The probe has the advantages of quick response, high sensitivity, good selectivity and light stability, capability of effectively reducing the interference of the fluorescence of the biological sample and the like.
The invention provides a fluorescent probe DCCO, which is 7- (diethylamino) -3- (E) -3- (9-ethyl-9H-carbazole-3-yl) acryloyl) -2H-pyran-2-ketone, and has a structural formula as follows:
the invention provides a preparation method of a fluorescent probe DCCO, which comprises the following steps:
(1) dissolving 3-acetyl-7- (diethylamino) -2H-pyran-2-one and 9-ethyl-9H-carbazole-3-formaldehyde in an equal molar ratio in an ethanol/acetonitrile (1/1, V/V) mixed solution, adding piperidine dropwise, heating and refluxing for 30 hours until the solution turns red from orange, and tracking the reaction by TLC (V)Ethyl acetate:VPetroleum ether=1:3);
(2) After the reaction is finished, removing the solvent under reduced pressure, performing column chromatography separation by a gradient elution method, eluting with ethyl acetate/petroleum ether (1/3, V/V), and then eluting with ethyl acetate/petroleum ether (1/2, V/V) to obtain a crude product of the fluorescent probe;
(3) dissolving the crude product with diethyl ether, filtering and drying to obtain an orange flocculent pure product DCCO.
The synthetic route is as follows:
the invention provides a method for quantitatively detecting ClO by fluorescence-The method comprises the following steps:
(1) preparing 1mM fluorescent probe DCCO stock solution by using DMSO;
(2) 2.0mL of water/DMSO (1/1, v/v) system and 10.0. mu.L of stock fluorescent probe were added to a fluorescence cuvette and titration experiments were performed on a fluorescence spectrophotometer with ClO-The fluorescence intensity at 420nm is gradually enhanced, and the fluorescence intensity at 570nm is gradually weakened;
(3) with ClO-Concentration is plotted on the abscissa as the relative fluorescence intensity I420nm/I570nmDrawing a graph for the ordinate and carrying out Sigmoidal fitting, wherein the linear regression equation is as follows: i is420nm/I570nm=0.033*[NaClO]-1.586, NaClO concentration in 10 units-6mol/L; linear correlation coefficient of R2The optimal linear response range is 53.6 μ M-375.2 μ M, 0.994.
Stability experiments prove that the fluorescent probe is directed to ClO-The assay of (2) has good light stability.
Experiments prove that common anions and biological mercaptan do not interfere ClO of a system-The measurement of (1).
The fluorescent probe DCCO of the invention proves that the fluorescent probe DCCO can be used for detecting ClO in biological samples by the laser confocal microscope imaging technology-And (4) changing.
Compared with the existing fluorescent probe, the synthesized fluorescent probe DCCO has the following advantages: 1. the fluorescent probe of the invention has simple synthesis steps and low cost. 2. The detection method is simple and can be realized only by means of a fluorescence spectrometer. 3. Fluorescent probeDCCO to ClO-The response has the characteristics of short response time, high sensitivity, good selectivity and the like, and is not interfered by common anions and biological mercaptan. 4. The ratio type fluorescent probe effectively eliminates the interference of environmental factors. 5. The fluorescent probe DCCO can be used for ClO in cells, zebra fish and arabidopsis thaliana-Detection of (3).
Drawings
FIG. 1 example 2 fluorescent Probe DCCO with ClO-Modified ultraviolet absorption spectrum
FIG. 2 example 3 fluorescent Probe DCCO with ClO-Varied fluorescence titration map
FIG. 3 example 3 fluorescent probes DCCO vs ClO-Operating curve of response
FIG. 4 example 4 fluorescent Probe DCCO response to common anions
FIG. 5 example 5Hella cytogram
Figure 6 imaging of zebra fish of embodiment 6
FIG. 7 imaging diagram of Arabidopsis thaliana in example 7
Detailed Description
EXAMPLE 1 preparation of fluorescent Probe DCCO
(1) Dissolving 3-acetyl-7- (diethylamino) -2H-pyran-2-one (0.777g, 3mmol) and 9-ethyl-9H-carbazole-3-carbaldehyde (0.669g, 3mmol) in 15mL of an ethanol/acetonitrile (1/1, V/V) mixed solution, adding piperidine (0.75mL, 7.5mmol) dropwise, refluxing under heating for 30 hours until the reaction solution turns red from orange, and performing TLC (V follow-up reaction)Ethyl acetate:VPetroleum ether=1:3);
(2) After the reaction is finished, removing the solvent under reduced pressure, performing column chromatography separation by a gradient elution method, eluting with ethyl acetate/petroleum ether (1/3, V/V) at first, and then eluting with ethyl acetate/petroleum ether (1/2, V/V) to obtain 0.699g of a crude product;
(3) the crude product was dissolved in ether, filtered and dried to give 0.349g of pure product as an orange yellow product with a yield of 25%.
For fluorescent probes1H NMR characterization, results are as follows:
1H NMR(600MHz,DMSO-d6,δ/ppm):δ8.61(s,1H),8.55(s,1H),8.24(d,J=7.6Hz,1H),7.99(d,J=15.6Hz,1H),7.91(d,J=15.6Hz,1H),7.87(d,J=8.4Hz,1H),7.71(s,1H),7.69(s,1H),7.66(d,J=8.1Hz,1H),7.50(t,J=7.6Hz,1H),7.26(t,J=7.3Hz,1H),6.82(d,J=8.9Hz,1H),6.63(s,1H),4.48(d,J=6.8Hz,2H),3.51(d,J=6.6Hz,4H),1.34(t,J=6.7Hz,3H),1.16(t,J=6.6Hz,6H).
13C NMR(150MHz,DMSO-d6,δ/ppm):185.89,160.45,158.60,153.30,148.57,144.41,141.42,140.54,132.70,126.81,126.60,126.31,123.14,122.63,122.47,122.34,121.19,120.01,116.52,110.61,110.26,110.08,108.38,96.38,44.91,37.68,14.25,12.85.
EXAMPLE 2 fluorescent Probe DCCO with ClO-Modified ultraviolet absorption spectrum
ClO was performed by adding 10.0. mu.L of stock fluorescent probe to 2.0mL of water/DMSO (1/1, v/v) system-Uv titration experiments were performed and uv absorption spectra were recorded (figure 1). With ClO-As the amount increased, the UV absorption at 290nm, 321nm and 355nm increased, and the UV absorption at 480nm decreased.
EXAMPLE 3 fluorescent Probe DCCO with ClO-Varied fluorescence titration map
ClO was performed by adding 10.0. mu.L of stock solution of fluorescent probe to a 2.0mL system of water/DMSO (1/1, v/v)-Fluorescence titration experiment, detection on a fluorescence spectrophotometer, with ClO-The increase in fluorescence intensity at 570nm gradually decreased, and a new peak appeared at 420nm and gradually increased (FIG. 2). The instrument parameters are that the slit widths of the excitation wavelength and the emission wavelength are respectively 5.0nm and 5.0nm, the voltage is 600V, and the maximum excitation wavelength of the fluorescent probe solution is as follows: lambda [ alpha ]exAt 335nm and a maximum emission wavelength of lambdaem570 nm. By the ratio of fluorescence I420nm/I570nmPlotting the plot for ordinate to obtain ClO-Working curve of concentration, linear regression equation is I420nm/I570nm=0.033*[NaClO]-1.586, NaClO concentration in 10 units-6mol/L; linear correlation coefficient of R2The optimal linear response range was 53.6 μ M-375.2 μ M (fig. 3), 0.994.
Example 4 response of fluorescent probes to common anionic and Biothiols
Add 10.0. mu.L of fluorescent probe stock to a 2.0mL system of water/DMSO (1/1, v/v), and add additional anion and biological thiol (F) respectively-、Ac-、CNS-、S2-、SO3 2-、CO3 2-、Br-、HCO3 -、SO4 2-、S2O3 2-、Cl-、HSO3 -GSH and Cys) to the final concentration of 250 μ M, respectively measuring the fluorescence spectra, and plotting the corresponding fluorescence intensity ratios I of different anions and biological thiol420nm/I570nmIs shown in the figure. Experiments prove that other anions and biological mercaptan do not interfere the ClO pair system-Detection of (2) (fig. 4).
Example 5 imaging of Hella cells
HeLa cells in DMEM medium, 5% CO2And culturing at 37 ℃. Prior to CLSM imaging, cells were seeded on 14mm glass coverslips and incubated for 12 hours, and the cells were plated out into multiple small petri dishes prior to use. The culture solution of the two small petri dishes was extracted and washed with PBS buffer solution at pH 7.40, and then, 2.0ml PBS (pH 7.40) buffer solution containing 20.0 μ L of probe (1mM, dissolved in DMSO) was added to each of the two small petri dishes to incubate for about 5min, followed by extraction and three-time washing with PBS buffer solution at pH 7.40. To one of the small petri dishes was added a solution containing 10.0. mu.L (1X 10)-2M)ClO-The cells were incubated in 2.0mL of a PBS buffer solution with pH 7.4 for about 10min, and then extracted, followed by washing with a PBS buffer solution with pH 7.40. Finally, the cells incubated with the probe and the hypochlorite are respectively placed in a small culture dish, and 2.0mL of PBS solution with pH value of 7.40 is added to observe under a laser confocal microscope. The fixed excitation wavelength is 405nm, and the collection emission bands are a blue channel (405-. As can be seen from FIG. 5, when only the probe was added, the cells exhibited strong yellow fluorescence and weak blue fluorescence (A1-D1), and HSO was added3 -The latter yellow color decreased, while the blue fluorescence increased (A2-D2).
Example 6 zebra fish imaging
Zebra fish cultured in E3 medium and maintained at 28 deg.C, and 5-day-old zebra fish incubated in culture solution containing 10 μ M probe for 15min, and part of the zebra fish was used for imaging, and the other part was incubated in culture solution containing ClO-The culture broth (μm) was further incubated for 10min, and zebrafish were rinsed three times with PBS buffer before imaging. The fixed excitation wavelength is 405nm, and the collection emission bands are a blue channel (405-. As shown in FIG. 6, after incubation with the probe, zebrafish fluoresced strongly in the yellow channel and weakly in the blue channel (A1-D1). When further ClO is used-After incubation, the yellow fluorescence decreased and the blue fluorescence increased (A2-D2).
EXAMPLE 7 Arabidopsis thaliana imaging
The method comprises the following steps of (1) disinfecting arabidopsis seeds, sowing the seeds on an MS/2 solid culture medium, carefully and freehand transferring the seeds to a self-made float after 10 days, and putting the seeds into a culture solution; after two days, the seedlings were transferred to a perforated foam plate (the holes were slightly smaller than the floats) and the seedlings after 10 days were taken as experimental materials for future use. Before imaging experiment, using tweezers to take small segments of fibers of arabidopsis thaliana, washing the fibers with PBS buffer solution, putting the fibers into culture solution containing 10 mu M fluorescent probe, incubating for 15min, washing and imaging a part of the fibers, adding ClO into the other part of the fibers-Culture broth (μm), further incubation for 10min, washing and imaging. The fixed excitation wavelength is 405nm, and the collection emission bands are a blue channel (405-. As shown in FIG. 7, after incubation with the probe, Arabidopsis fluoresced strongly in the yellow channel and weakly in the blue channel (A1-D1). When further ClO is used-After incubation, the yellow fluorescence decreased and the blue fluorescence increased (A2-D2).
Claims (5)
3. the method for preparing the fluorescent probe DCCO according to claim 1, comprising the steps of:
(1) dissolving 3-acetyl-7- (diethylamino) -2H-pyran-2-one and 9-ethyl-9H-carbazole-3-formaldehyde in an equal molar ratio in a mixed solution of ethanol and acetonitrile with the same volume, dripping piperidine, heating and refluxing for 30 hours until the solution turns red from orange, and tracking the reaction by TLC;
(2) after the reaction is finished, removing the solvent under reduced pressure, and performing column chromatography separation by using a gradient elution method, wherein the volume ratio of the solvent to the solvent is 1: 3, eluting with ethyl acetate and petroleum ether, and then adding a solvent with a volume ratio of 1: 2, eluting the eluent of ethyl acetate and petroleum ether to obtain a crude product of the fluorescent probe;
(3) dissolving the crude product with diethyl ether, filtering and drying to obtain an orange pure product DCCO.
4. Quantitative fluorescence detection ClO-The method is characterized by comprising the following steps:
(1) preparing 1mM stock solution of the fluorescent probe DCCO according to claim 1 in DMSO;
(2) mixing 2.0mL of the mixture in a volume ratio of 1: 1 System of Water and DMSO and 10.0. mu.L of DCCO stock solution were added to a fluorescence cuvette and the titration experiment was performed on a fluorescence spectrophotometer with ClO-The fluorescence intensity at 420nm is gradually enhanced, and the fluorescence intensity at 570nm is gradually weakened;
(3) with ClO-Concentration is plotted on the abscissa as the relative fluorescence intensity I420nm/I570nmDrawing a graph for the ordinate and carrying out Sigmoidal fitting, wherein the linear regression equation is as follows: i is420nm/I570nm=0.033*[NaClO]-1.586, NaClO concentration in 10 units-6mol/L; linear correlation coefficient of R20.994, the optimal linear response range is 53.6 μ M-375.2 μ M;
the method is non-disease diagnostic or therapeutic.
5. The fluorescent probe DCCO as claimed in claim 1 for use in ClO of biological sample-The assay of (1), said assay being non-disease diagnostic or therapeutic.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910634808.8A CN110272731B (en) | 2019-07-15 | 2019-07-15 | Fluorescent probe DCCO and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910634808.8A CN110272731B (en) | 2019-07-15 | 2019-07-15 | Fluorescent probe DCCO and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110272731A CN110272731A (en) | 2019-09-24 |
CN110272731B true CN110272731B (en) | 2021-05-14 |
Family
ID=67964337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910634808.8A Active CN110272731B (en) | 2019-07-15 | 2019-07-15 | Fluorescent probe DCCO and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110272731B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110627756B (en) * | 2019-10-10 | 2023-03-17 | 中国科学院新疆理化技术研究所 | Colorimetric-fluorescent probe for detecting hypochlorite and preparation method and application thereof |
CN112745287B (en) * | 2020-12-30 | 2022-03-18 | 山西大学 | Fluorescent probe HM and preparation method and application thereof |
CN113218922B (en) * | 2021-03-12 | 2022-09-16 | 天津理工大学 | Coumarin skeleton-based rapid hypochlorite ratio detection type fluorescent probe and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105837558A (en) * | 2016-04-22 | 2016-08-10 | 山西大学 | Reagent and method for fluorescence detection of hypochlorous acid |
CN105968094A (en) * | 2016-05-30 | 2016-09-28 | 山西大学 | Carbazole fluorescent probe for detecting ClO- and preparation method and application thereof |
CN109988560A (en) * | 2019-05-17 | 2019-07-09 | 济南大学 | A kind of hydrazine fluorescence probe of novel coumarin derivative |
-
2019
- 2019-07-15 CN CN201910634808.8A patent/CN110272731B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105837558A (en) * | 2016-04-22 | 2016-08-10 | 山西大学 | Reagent and method for fluorescence detection of hypochlorous acid |
CN105968094A (en) * | 2016-05-30 | 2016-09-28 | 山西大学 | Carbazole fluorescent probe for detecting ClO- and preparation method and application thereof |
CN109988560A (en) * | 2019-05-17 | 2019-07-09 | 济南大学 | A kind of hydrazine fluorescence probe of novel coumarin derivative |
Also Published As
Publication number | Publication date |
---|---|
CN110272731A (en) | 2019-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110272731B (en) | Fluorescent probe DCCO and preparation method and application thereof | |
Liu et al. | A new fluorescent and colorimetric probe for Cu 2+ in live cells | |
Suzuki | Design and synthesis of fluorescent reagents for selective detection of dopamine | |
Li et al. | A near-infrared fluorescent probe for Cu2+ in living cells based on coordination effect | |
CN107056769A (en) | A kind of L cysteines fluorescence probe and preparation method thereof | |
CN108003869B (en) | Fluorescent probe for detecting hypochlorite with high sensitivity and synthesis method and application thereof | |
Peng et al. | A novel fluorescent probe for selective detection of hydrogen sulfide in living cells | |
CN106749034B (en) | Ratio-type fluorescent labeling reagent and its synthetic method and application are answered to bisulfite and hypochlorite double-bang firecracker | |
CN113999219B (en) | Double-site fluorescent probe and synthetic method and application thereof | |
CN110156688B (en) | Fluorescent probe for detecting polarity of targeted endoplasmic reticulum and application thereof | |
Qian et al. | Living cells imaging for copper and hydrogen sulfide by a selective “on–off–on” fluorescent probe | |
CN112745287B (en) | Fluorescent probe HM and preparation method and application thereof | |
CN111285833A (en) | Detection ONOO-Ratiometric fluorescent molecular probe and preparation method and application thereof | |
Ding et al. | Design, synthesis and bioimaging application of a novel two-photon xanthene fluorescence probe for ratiometric visualization of endogenous peroxynitrite in living cells and zebrafish | |
CN111253935A (en) | Two-photon fluorescent probe for detecting polarity and viscosity through two channels and preparation method and application thereof | |
Xu et al. | A fast-responsive two-photon fluorescent turn-on probe for nitroreductase and its bioimaging application in living tissues | |
CN108398409B (en) | Method for detecting hypochlorite by fluorescence ratio | |
CN107311977B (en) | Indole ethylene compound and preparation method and application thereof | |
Liu et al. | Rhodamine based turn-on fluorescent sensor for Hg2+ and its application of microfluidic system and bioimaging | |
Wang et al. | An ‘‘off–on–off’’sensor for sequential detection of Cu 2+ and hydrogen sulfide based on a naphthalimide–rhodamine B derivative and its application in dual-channel cell imaging | |
Qiu et al. | A Fluoran-based Cu 2+-selective fluorescent probe and its application in cell imaging | |
CN106631980B (en) | A kind of water-soluble biological thiol two-photon fluorescence probe and its preparation method and application | |
CN108484479B (en) | Carbazolyl two-photon fluorescent probe and preparation method and application thereof | |
CN113061109B (en) | Morpholine-pyridine-merocyanine derivative fluorescent probe and preparation method and application thereof | |
CN104946244B (en) | Detect O2·‑Fluorescent molecular probe, its synthetic method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |